Im Cannabis Stock Insiders

All Insiders . USA . 
Stock . Im Cannabis Corp . Stakeholders
IMCC Stock  USD 0.24  -0.02  -7.69%   
Im Cannabis' ownership page maps who actually holds Im Cannabis -- institutions, insiders, and the wider shareholder base. The split between insider and institutional ownership shapes governance dynamics and voting outcomes.
  

Management Team Effectiveness

IMCC has return on total asset (ROA) of -10.92% pointing to operating inefficiency. Negative, confirming a loss position in the current period. Im Cannabis also reports a return on stockholder's equity (ROE) of -119.75%, meaning that it is delivering a negative return on shareholder investment.
Using the latest reported data from December 31, 2025, Common Stock Shares Outstanding is near current levels at 4.24 million.

Stock Institutional Investors

At micro-cap scale, institutional coverage and secondary-market liquidity are typically well established. At Im Cannabis Corp's scale, retail participation has a bigger role in day-to-day price moves. Shares outstanding are near 6.22 million. The insider stake is large enough to signal management alignment, which can steady the price during sell-offs.
Shares
Td Waterhouse Canada Inc2025-12-31
12.0
Bryn Mawr Trust Company2025-12-31
9.0
Group One Trading, Lp2025-12-31
2.0
Yorkville Advisors Global, Lp2025-12-31
0.0
Renaissance Technologies Corp2025-12-31
0.0
Fny Investment Advisers, Llc2025-12-31
0.0
Advisorshares Investments, Llc2025-12-31
102.1 K
Heron Bay Capital Management2025-12-31
25.9 K
Drw Securities, Llc2025-12-31
23.1 K
Hidden Cove Wealth Management, Llc2026-03-31
14.3 K
Bank Of Montreal2025-12-31
11.9 K
For a smaller-cap like Im Cannabis Corp (1.63 million), benchmark pressure and redemption cycles can limit how institutional weight turns into price support. The business currently sits in the Healthcare sector and the Drug Manufacturers—Specialty & Generic industry. Institutional flows, insider activity, and short interest together distinguish passive index allocation from active positioning for a smaller-cap like Im Cannabis Corp.

Outstanding Bonds

Im Cannabis Corp may use bonds as part of its capital structure to fund operations, refinance liabilities, or support acquisitions and other long-duration investments. At micro-cap scale, institutional coverage and secondary-market liquidity are typically well established. Bond investors and equity investors often care about the same cash flows, but they rank the risks differently.
MPLX LP 4125 Corp Bond
US55336VAK61		View
Morgan Stanley Jul Corp Bond
US61744YAK47		View
Morgan Stanley 3971 Corp Bond
US61744YAL20		View
MGM Resorts International Corp Bond
US552953CD18		View
Valero Energy Partners Corp Bond
US91914JAA07		View
Im Cannabis carries a considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
 
Shares in Circulation  
 First Issued
1997-06-30
 Previous Quarter
4.87 million
 Current Value
4.24 million
 Average Shares Outstanding
919,542
 Quarterly Volatility
1.75 million
Macro event markers
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes

Holders Distribution

For Im Cannabis Corp, institutional participation can be supportive or destabilizing depending on whether large holders are building conviction or reducing exposure. The analytical value is not in imitation, but in understanding how large-holder positioning may affect liquidity, volatility, and timing.

Market Cap and Value

Workforce Comparison

Im Cannabis Corp is currently under evaluation for number of employees relative to top peers. The total workforce of Health Care industry is currently estimated at about 505. Im Cannabis adds roughly 0 in number of employees claiming only tiny portion of equities under Health Care sector.

Profit Margins

IMCC has Profit Margin (PM) of -21.0%. Similarly, it shows Operating Margin (OM) of -31.0%.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin17.00%18.00%
Notably Down
Moderate Decline

Benchmark Summation

Operator
This analysis covers sixty-one data points across the selected time horizon. Price Series Summation combines Im Cannabis's price with its benchmark or peer at each point in time. The resulting line reflects the combined price movement of both instruments, which can be useful for analyzing correlated pairs or constructing synthetic composite indicators.

Notable Stakeholders

Stakeholders matter for Im Cannabis because not every influential participant is a shareholder acting with the same objective or time horizon. The practical value is in seeing where interests align, where they conflict, and how that tension could influence execution.
Oren ShusterCEO & Executive DirectorProfile
Richard BallaCEO of AdjupharmProfile
Eyal FisherCEO of the IMC HoldingsProfile
MSc MBAExecutive ChairmanProfile
Asi LeviCFOProfile
Anna TarankoDirector Investor & Public RelationsProfile
Advocate NissimovGeneral SecretaryProfile
Michael RuscettaChief CorpProfile
Advocate HarroshChief OfficerProfile
Uri BirenbergChief OfficerProfile
Shai ShemeshChief OfficerProfile
Rinat EfrimaChief IsraelProfile
Howard CFAChief MYMProfile

Management Information & Data Sources

Im Cannabis is a micro-cap company across Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Management effectiveness is reflected in operating results, capital allocation choices, and margin durability. Margin trends and reinvestment returns reveal whether management is creating or eroding shareholder value. CEO is Oren Shuster with 13 employees and 13 reported executives.

Im Cannabis Corp values are built from periodic company reporting and market reference feeds, with reporting definitions aligned before display. Insider and management fields are mapped from published filings and company disclosures.

Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board

Workforce Efficiency and Productivity

Workforce efficiency at Im Cannabis Corp measures execution quality, especially when comparing similar businesses in the same industry. Comparing these measures with sector norms matters because labor intensity varies meaningfully across industries.

Im Cannabis Manpower Efficiency

Return on Im Cannabis Manpower

Revenue Per Employee4.2M
Revenue Per Executive4.2M
Net Loss Per Employee903.8K
Net Loss Per Executive903.8K

Popular Tools for IMCC Stock analysis

Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for riskPortfolio AnywhereTrack or share privately all of your investments from the convenience of any deviceEconomic IndicatorsTop statistical indicators that provide insights into how an economy is performingMoney ManagersScreen money managers from public funds and ETFs managed around the worldInstant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performancePattern RecognitionUse different Pattern Recognition models to identify potential trend changes across multiple global exchangesHeadlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticityUSA ETFsFind actively traded Exchange Traded Funds (ETF) in USACEOs DirectoryScreen CEOs from public companies around the world
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.